T cell avidity determines the level of CTL activation

Area of Science:

• Immunology
• T cell biology
• Molecular immunology

Background:

• T cell avidity, a measure of binding strength, is crucial for immune responses.
• Understanding avidity's role in T cell activation is key to developing effective immunotherapies.

Purpose of the Study:

• To investigate how varying T cell avidity affects T cell activation in vitro and in vivo.
• To establish a model system for studying T cells with identical specificity but different avidities.

Main Methods:

• Utilized transgenic mouse models (St40 and St42) with identical TCRs but differing expression levels (avidity).
• Assessed T cell activation markers (CD25), cytolytic activity, proliferation, and cytokine secretion (IL-2, IFN-gamma) in vitro.
• Evaluated T cell expansion and persistence in vivo following adoptive transfer and adenovirus immunization.

Main Results:

• Comparable cytolytic activity and peptide concentration requirements were observed between high- and low-avidity T cells.
• High-avidity T cells exhibited rapid CD25 upregulation, while low-avidity T cells showed delayed and reduced expression.
• Low-avidity T cells demonstrated impaired proliferation, reduced IL-2 and IFN-gamma secretion, and poor in vivo persistence.

Conclusions:

• T cell avidity critically influences the kinetics and magnitude of T cell activation and effector function.
• High-avidity T cells are more effective in vivo, highlighting avidity as a key factor in immune response efficacy.
• The developed model system enables further investigation into the interplay between T cells of differing avidities during immune responses.